Filing Flows › BioAge Labs (BIOA) › R&D spending
BioAge Labs (BIOA) R&D spending by quarter
BioAge Labs' R&D spending was $30.2M in Q3 2026 (third quarter 2026), +24% from Q2 2026. Over the last 7 quarters it ranged from $11.1M (Q1 2025) to $30.2M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $30.2M | +24% | +63% |
| Q2 2026 | $24.4M | +19% | +23% |
| Q1 2026 | $20.4M | -17% | +84% |
| Q4 2025 | $24.5M | +32% | — |
| Q3 2025 | $18.5M | -7% | — |
| Q2 2025 | $19.8M | +79% | — |
| Q1 2025 | $11.1M | — | — |
Q3 2026 at a glance
BioAge Labs, Q3 2026: revenue $298K (-86% year over year), net loss $33.5M, operating cash flow −$31.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is BioAge Labs' R&D spending?
BioAge Labs' R&D spending was $30.2M in Q3 2026 (third quarter 2026), +24% from Q2 2026.
How has BioAge Labs' R&D spending changed?
Over the last 7 quarters it ranged from $11.1M (Q1 2025) to $30.2M (Q3 2026).